The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Molex's revenues will contract -1.8% and EPS will decrease -13.0%.
The average estimate for revenue is $919.6 million. On the bottom line, the average EPS estimate is $0.40.
Last quarter, Molex notched revenue of $858.5 million. GAAP reported sales were 6.0% lower than the prior-year quarter's $913.7 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.35. GAAP EPS of $0.41 for Q4 were 6.8% lower than the prior-year quarter's $0.44 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 30.0%, 80 basis points worse than the prior-year quarter. Operating margin was 10.3%, 210 basis points worse than the prior-year quarter. Net margin was 8.4%, 10 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $3.76 billion. The average EPS estimate is $1.67.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 135 members out of 152 rating the stock outperform, and 17 members rating it underperform. Among 47 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 44 give Molex a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Molex is hold, with an average price target of $27.21.
Can your retirement portfolio provide you with enough income to last? You'll need more than Molex. Learn about crafting a smarter retirement plan in "The Shocking Can't-Miss Truth About Your Retirement." Click here for instant access to this free report.
- Add Molex to My Watchlist.